Joshua Hexter

2017

In 2017, Joshua Hexter earned a total compensation of $691.3K as Chief Operating Officer and VP Business Development at Oramed Pharmaceuticals, a 165% increase compared to previous year.

Compensation breakdown

Bonus$33,000
Salary$148,499
Stock Awards$463,400
Other$46,408
Total$691,307

Hexter received $463.4K in stock awards, accounting for 67% of the total pay in 2017.

Hexter also received $33K in bonus, $148.5K in salary and $46.4K in other compensation.

Rankings

In 2017, Joshua Hexter's compensation ranked 10,668th out of 14,666 executives tracked by ExecPay. In other words, Hexter earned more than 27.3% of executives.

ClassificationRankingPercentile
All
10,668
out of 14,666
27th
Division
Manufacturing
4,156
out of 5,770
28th
Major group
Chemicals And Allied Products
1,480
out of 2,074
29th
Industry group
Drugs
1,209
out of 1,730
30th
Industry
Pharmaceutical Preparations
939
out of 1,329
29th
Source: SEC filing on July 30, 2018.

Hexter's colleagues

We found two more compensation records of executives who worked with Joshua Hexter at Oramed Pharmaceuticals in 2017.

2017

Miriam Kidron

Oramed Pharmaceuticals

Chief Scientific Officer

2017

Nadav Kidron

Oramed Pharmaceuticals

Chief Executive Officer

News

You may also like